Fidelity Select Biotechnology Portfolio (FBIOX)
| Fund Assets | 5.15B |
| Expense Ratio | 0.62% |
| Min. Investment | $0.00 |
| Turnover | 45.00% |
| Dividend (ttm) | 1.62 |
| Dividend Yield | 6.47% |
| Dividend Growth | 611.40% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Apr 10, 2026 |
| Previous Close | 25.17 |
| YTD Return | 4.00% |
| 1-Year Return | 53.93% |
| 5-Year Return | 38.05% |
| 52-Week Low | 17.34 |
| 52-Week High | 26.24 |
| Beta (5Y) | 0.56 |
| Holdings | 198 |
| Inception Date | Dec 16, 1985 |
About FBIOX
The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
Performance
FBIOX had a total return of 53.93% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.56%.
Top 10 Holdings
48.55% of assets| Name | Symbol | Weight |
|---|---|---|
| Krystal Biotech, Inc. | KRYS | 8.99% |
| Gilead Sciences, Inc. | GILD | 8.44% |
| AbbVie Inc. | ABBV | 8.01% |
| Amgen Inc. | AMGN | 7.78% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 3.26% |
| Insmed Incorporated | INSM | 3.14% |
| Praxis Precision Medicines, Inc. | PRAX | 2.42% |
| Ascendis Pharma A/S | ASND | 2.21% |
| UCB SA | UCB | 2.21% |
| argenx SE | ARGX | 2.08% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Apr 10, 2026 | $1.063 | Apr 13, 2026 |
| Dec 12, 2025 | $0.559 | Dec 15, 2025 |
| Apr 11, 2025 | $0.062 | Apr 14, 2025 |
| Dec 13, 2024 | $0.166 | Dec 16, 2024 |
| Apr 12, 2024 | $0.063 | Apr 15, 2024 |
| Dec 27, 2023 | $0.002 | Dec 28, 2023 |